Aim of the educational conference

Immunotherapy is now emerging as a promising treatment option for cancer patients. The concept of cancer immunotherapy dates back to the late nineteenth century. Since then, considerable knowledge has been obtained on different strategies aimed to induce specific antitumor response. Cancer immunotherapy includes active immunization, such as therapeutic cancer vaccines, and passive immunization, such as monoclonal antibodies that activate endogenous immune response against tumor cells.

Recent positive results from clinical trials in cancer immunotherapy demonstrate the potential of immune-based strategies to provide effective treatment in a variety of cancer types. The combination of standard chemotherapy and radiation therapy with cancer immunotherapy is currently under evaluation.

Learning objectives

After attending the live educational conference, learners will be able to:

• discuss different strategies in cancer immunotherapy
• summarize recent advances in the development and clinical application of cancer immunotherapy in prostate, lung and breast cancer
• identify biomarkers of efficacy to guide immune-based cancer therapies

For more information

For more information please download the brochure

Target audience

Oncologists, immunologists, biologists and other health care professionals involved in cancer immunotherapy research.

Accreditation

An application has been made to the EACCME ® and to the ESMO ® for CME accreditation of the SSIF Conference on “Immunotherapy: current knowledge and controversies” to be held on July 5-6, 2013 in Valencia, Spain.